Humana CenterWell premiums and services revenue detail
CenterWell premiums and services revenue detail at Humana came to $6,790 for the quarter to 30 Jun 2026, up 22.6% from a year earlier.
As Humana reported it in its earnings release and quarterly or annual report, compiled and checked by AapWire. Latest figure filed 29 Jul 2026.
By quarter
| Period ending | CenterWell premiums and services revenue detail | Change on a year | Filed |
|---|---|---|---|
| 30 Jun 2026 | $6,790 | up 22.6% | 29 Jul 2026 |
| 31 Mar 2026 | $6,100 | up 19.7% | 29 Apr 2026 |
| 31 Dec 2025 | $5,962 | up 16.2% | 11 Feb 2026 |
| 30 Sep 2025 | $5,879 | up 16.6% | 5 Nov 2025 |
| 30 Jun 2025 | $5,537 | up 11.9% | 30 Jul 2025 |
| 31 Mar 2025 | $5,095 | up 5.7% | 30 Apr 2025 |
| 31 Dec 2024 | $5,130 | up 8.9% | 11 Feb 2025 |
| 30 Sep 2024 | $5,041 | up 8.2% | 30 Oct 2024 |
| 30 Jun 2024 | $4,947 | up 9.2% | 31 Jul 2024 |
| 31 Mar 2024 | $4,818 | up 6.9% | 24 Apr 2024 |
| 31 Dec 2023 | $4,710 | up 13.8% | 18 Jan 2024 |
| 30 Sep 2023 | $4,660 | — | 1 Nov 2023 |
| 30 Jun 2023 | $4,530 | — | 2 Aug 2023 |
| 31 Mar 2023 | $4,505 | — | 26 Apr 2023 |
| 31 Dec 2022 | $4,139 | — | 1 Feb 2023 |
Definition
Revenue from this part of the business, as the company names and reports it in its results. Each figure is read from the table or sentence the company printed and kept with its scale and decimals; see data and methodology.
Other operating KPIs of Humana: Premiums and services revenue detail (State-based contracts and other · Insurance) · Home Solutions episodic admissions · PPO/PFFS individual medicare advantage membership · CenterWell, Pharmacy solutions premiums and services revenue detail · CenterWell, Primary care premiums and services revenue detail · CenterWell, Home solutions premiums and services revenue detail · Mail-Order penetration (Pharmacy Solutions, Total Medicare) · External Revenues · Services revenue · Insurance revenue · CenterWell revenue · financial statements
Every KPI and segment of HUM, in the terminal.
Ten years of operating figures, segments, guidance against results, charts and alerts on each new release.
